Your browser doesn't support javascript.
loading
Mutations in the nonstructural proteins of SARS-CoV-2 may contribute to adverse clinical outcome in patients with COVID-19.
Ichikawa, Takaya; Torii, Shiho; Suzuki, Hikoyu; Takada, Akio; Suzuki, Satoshi; Nakajima, Masahide; Tampo, Akihito; Kakinoki, Yasutaka.
  • Ichikawa T; Division of Internal Medicine, Asahikawa City Hospital, Asahikawa, Japan. Electronic address: ichikawa.honest2.go@gmail.com.
  • Torii S; Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.
  • Suzuki H; Digzyme Inc., Tokyo, Japan.
  • Takada A; Department of Pathology, Asahikawa City Hospital, Asahikawa, Japan.
  • Suzuki S; Division of Internal Medicine, Asahikawa City Hospital, Asahikawa, Japan.
  • Nakajima M; Department of Pediatrics, Asahikawa City Hospital, Asahikawa, Japan.
  • Tampo A; Department of Emergency Medicine, Asahikawa City Hospital, Asahikawa, Japan.
  • Kakinoki Y; Division of Internal Medicine, Asahikawa City Hospital, Asahikawa, Japan.
Int J Infect Dis ; 122: 123-129, 2022 Sep.
Article en En | MEDLINE | ID: mdl-35562044
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article